CELH
Overvalued by 34.3% based on the discounted cash flow analysis.
Market cap | $9.47 Billion |
---|---|
Enterprise Value | $8.62 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.62 |
Beta | 1.57 |
Outstanding Shares | 188,760,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 47.8 |
---|---|
PEG | -54.26 |
Price to Sales | 4.99 |
Price to Book Ratio | 5.83 |
Enterprise Value to Revenue | 6.29 |
Enterprise Value to EBIT | 37.33 |
Enterprise Value to Net Income | 41 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0.03 |
No data
No data
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...